A deletion mutant of influenza virus haemagglutinin (HA; headless HA) lacking the globular region was expressed in CV-I cells and detected with a monoclonal antibody, C179, which recognizes a conformational epitope in the middle of the stem region of HA and neutralizes all H 1 and H2 subtypes. The cDNA coding for the headless HA was constructed from influenza virus A/Okuda/57 (H2N2), which was also used to select C179. The conformational epitope recognized by C 179 was highly stable even after removal of the globular region. The survival rate of mice immunized with the headless HA and challenged with lethal influenza virus A/FM/1/47 (HIN1) was significantly higher than that of the control mice. The headless HA has the potential to induce cross-protection against influenza virus infection.
A deletion mutant of influenza virus haemagglutinin (HA; headless HA) lacking the globular region was expressed in CV-I cells and detected with a monoclonal antibody, C179, which recognizes a conformational epitope in the middle of the stem region of HA and neutralizes all H 1 and H2 subtypes. The cDNA coding for the headless HA was constructed from influenza virus A/Okuda/57 (H2N2), which was also used to select C179. The conformational epitope recognized by C 179 was highly stable even after removal of the globular region. The survival rate of mice immunized with the headless HA and challenged with lethal influenza virus A/FM/1/47 (HIN1) was significantly higher than that of the control mice. The headless HA has the potential to induce cross-protection against influenza virus infection.
The haemagglutinin (HA) of influenza virus has two functions that are essential for the initiation of influenza virus infection (Wiley & Skehel, 1987) and which involve two structurally distinct regions, the globular head and stem . The globular region contains a receptorbinding site that is responsible for virus attachment to the target cell, whereas the stem region contains a fusion peptide that induces membrane fusion between the viral envelope and the endosomal membrane of the cell.
We produced a monoclonal antibody (MAb), C179, that neutralizes both H1 and H2 subtype strains to almost the same degree, but does not neutralize viruses of the H3 subtype (Okuno et al., 1993) . Analysis of the nucleotide and deduced amino acid sequences of escape mutants revealed that C179 recognized a conformational epitope in the middle of the stem region, comprising residues 318 to 322 of HA 1 and 47 to 58 of HA 2. Fusion inhibition assays showed that C179 neutralized Author for correspondence: Yuji Isegawa.
Fax +81 6 875 0534, e-mail isegawa@biken.osaka-u.ac.jp the viruses by inhibiting the fusion activity of the HA. Furthermore, mice injected with C179 before or after virus challenge were protected from lethal influenza virus infection (Okuno et aI., 1994) . However, neutralizing antibodies that recognize the stem region of HA (like C179) are not induced by virus infections or by current influenza vaccines . The globular head region contains the main antigenic determinants in which antigenic mutations arise. If the conformation of the stem region is conserved even after the deletion of the globular region, it may be useful as a vaccine that elicits neutralizing antibodies, such as CI79, to all the H1 and H2 influenza strains (Fig. I b) . Here we transformed CV-1 cells with plasmids containing the headless HA gene (Fig. la) , and the expressed antigens were detected using C179. Moreover, mice were immunized with the transfected cells and the protective effect was investigated by challenge using a mouse-adapted lethal influenza virus.
The HA gene was isolated from the influenza virus A/Okuda/57 (H2N2), which was also used to select MAb C179. To clone the cDNA of the HA gene, viral RNA in Madin-Darby canine kidney (MDCK) cells infected with the virus was extracted using guanidium isothiocyanate (Chirgwin et al., 1979) . The cDNA was synthesized using the oligonucleotide primer 5' AGCAAAAGCAGGGGATAAT 3', complementary to the 3' terminus of the genomic RNA. The cDNA was amplified by the PCR using the primers, 5' GATCTAGAAGCAAAAGCAGGGGTTATACCA 3', which was a combination of an XbaI site and the sequence complementary to the 3' terminus of the HA genomic strand, and 5' ACAGATCTAGTAGAAACAAGGGTGTTTTT 3', which was a combination of an XbaI site and the sequence of the positive-strand RNA. The first amplified DNA was further amplified by PCR using the primers, 5' CGGCTAGCAAA-AGCAGGGGTTATACCATAG 3', containing an NheI site and the sequence complementary to the 3' terminus of the genomic strand RNA, and 5' CGGCTAGCAGAAACAAGG-GTGTTTTTTT 3', containing an NheI site and the sequence complementary to the 3' terminus of the positive-strand RNA. The terminus of the fragment was blunt ended and inserted at the SmaI site of pHSG299 (Takeshita et al., 1987) . The resulting plasmid was termed pH2-299. A deletion mutant plasmid of pH2-299 lacking the sequence coding for the globular region of the HA molecule was constructed by PCR. The deleted region in the HA gene was from nucleotide residues 232 to 873 (642 nucleotides) of the cDNA as shown in Fig. 1 (a) . The 3"8 kbp DNA fragment, from which the globular region of the HA molecule was deleted, was amplified using a pair of primers, 5' TCCGTTTAG-TTTGCATAACTTTCCG 3', complementary to the nucleotide sequence from 207 to 231 of the HA gene, and 5' TCCGGGATCATGAAA_ACAGAAGGAAC 3', corresponding to nucleotides 874 to 899 but in which base 876 was changed from A to C. The fragment was blunt ended, phosphorylated and self-ligated to construct the plasmid p299H2Sn-c.
The shuttle vector pEF-BOS/neoA was constructed from the plasmid pEF-BOS (Mizushima & Nagata, 1990) by inserting a 2"6 kbp BamHI fragment containing the neoA gene using the SV40 promoter from pMAMneo-S (Clontech) at the AatI site (Fig. l a) . The 1"8 kbp NheI fragment from pH2-299 or the 1"1 kbp fragment from p299H2Sn-c was inserted at XbaI sites of pEF-BOS/neoA. These new vectors, pEBNaH2 and pENH2dH01, respectively (Fig. la) , were transfected into CV-I (monkey kidney) cells by electroporation using a Genepulser (Bio-Rad). The control, pEF-BOS/neoA, was processed in the same manner. The transfected cells were suspended in Dulbecco's modified Eagle's medium supplemented with i0% fetal bovine serum and were incubated in Petri dishes. After incubation for 3 days at 37 °C, epitope expression was confirmed by a peroxidase-antiperoxidase (PAP) staining technique using CI 79 (Okuno et at., I990) . The cells were fixed with absolute ethanol at room temperature for i0 min. They were then successively incubated with mouse ascitic fluid (C179) at a 1000-fold dilution, rabbit anti-mouse immunoglobulin G (IgG) serum (Organon Teknika) at a 1000-fold dilution, goat anti-rabbit IgG serum (Organon Teknika) at a 500-fold dilution and PAP complex (Organon Teknika) at a 5000-fold dilution. Each incubation was for 40 min and was followed by washing with PBS. Finally, the peroxidase reaction was developed for about 5 min using 0"01% H20 2 and 0"3 mg of 3,3'-diaminobenzidine tetrahydrochloride (Wako Chemical Industries) per ml in PBS.
The CV-1 cells transformed with both pEBNaH2 and pENH2dH01 were obviously stained (Fig. 2b, c) , but those transformed with pEF-BOS/neoA were not (Fig. 2 a) . These findings indicated that the conformational epitope recognized by C179 was conserved despite the deletion of the globular region of HA (Fig. I b) .
To investigate the immunological characteristics of the headless HA expressed in CV-I cells, mice were immunized with the transfected cells and challenged with a lethal influenza virus strain A/FM/1/47 (HIN1). The procedure for the preparation of CV-1 cells transformed with pENH2dH01 was as described above. Three days after the transfection, the CV-I cells were harvested, and suspended in PBS pH 7"4. Ten 4-week-old female BALB/c mice were intraperitoneally injected with 0"5 ml of PBS containing 1 x 106 cells. Two weeks after the first immunization, they were given a similar booster immunization (group P). The controls groups consisted of 10 mice injected with CV-1 cells transformed with pEF-BOS/ neoA (group N) and 10 mice injected with CV-1 cells transformed with pEBNaH2 (group F). In addition, the control group for the cytotoxic T lymphocyte (CTL) response consisted of 10 mice injected with heat4reated CV-1 cells transformed with pENH2dH01 (group C). All the mice in the three groups were inoculated intranasally with 25 ~tl (8 x 1 0 4 i.ii.i.iii.iii .iiiiiiiiiiiJiiiiiiiiiiiiiiii iii.i .i. i.i i.i. f.f.u.) of A/FM/1/47 1 week after the booster immunization and their survival rates were monitored for 15 days (Fig. 3) .
Nine of the 10 mice in group N, 9 of the 10 mice in group F and 7 of the 10 mice in group C died. However, only 3 of the 10 mice given CV-1 cells transfected with pENH2dH01 died. These findings suggest that CV-1 cells transfected with pENH2dH01 effectively reduce infection with influenza virus and that the stem region expressed in CV-1 cells plays an immunological role in mice.
As the challenge virus (A/FM/1/47) was a different subtype from the A/Okuda/57 strain from which the HA gene was inserted into the recombinant vector, the increased survival rates indicated cross-protection.
Group P showed a higher survival rate than groups C, F or N. In other words, higher cross-protection was induced by immunization with headless HA with a three-dimensional structure recognized by CI79 than with headless HA lacking preservation of structure or with complete HA. To induce high cross-protective activity the head region may need to be absent and the three-dimensional structure in the stem region preserved in a state recognized by C179. Most of the crossprotection activity obtained by immunization with headless HA may have been induced by an antibody recognizing the structure in the stem region. However, we could not detect anti-HA antibody in the serum of mice immunized with transformed cells. Nevertheless, this does not exclude the possibility of antibody involvement. We previously demonstrated protection against lethal influenza virus infection by intraperitoneal administration of a high dose of C179 to mice (Okuno et al., 1994) . In this experiment also, no C179 was detected in mouse serum (unpublished observation). These findings suggest that the C179-type antibody, recognizing the three-dimensional structure in the stem region, protects at a dose below the limit of detection. In addition, immunization with cells expressing complete HA had no effect suggesting that the induction of antibody against the head region may take priority and antibody recognizing the structure in the stem region may be difficult to induce. On the other hand, immunization with denatured headless HA had only a slightly more marked effect compared with control. This may be associated with cross-protective CTL, as Mbawuike et al. (1994) have reported the ability of HA 2 to induce crossprotective CTL. However, the differences in the survival rates described above indicate that most of the cross-protection is due to antibody recognizing the three-dimensional structure in the stem region and that the involvement of cross-protective CTL is only partial.
In addition, mice immunized with cells expressing headless HA and those immunized with cells not expressing headless HA were infected with a lethal influenza virus strain A/Guizhou-X (H3N2; Tamura et al., 1992) . The same clinical symptoms were observed in the H3 subtype influenza virus infection in both groups of mice (data not shown).
This study demonstrates that the conformational epitope recognized by CI79 is conserved even after removal of the globular region. The stem region, in which the amino acid sequence is conserved in each subtype, contains a fusion peptide that induces membrane fusion between the viral envelope and the endosomal membrane of a cell. The middle of the stem region undergoes a conformational change which is necessary for virus infection (Carr & Kim, 1993 . Moreover, mutant influenza viruses selected using C179 had amino acid substitutions at the middle of the stem region (Okuno et al., 1993) . The mutant viruses grew slowly in MDCK cells but hardly at all in eggs or mice (unpublished observation). Thus these amino acid substitutions may alter the conformation of the region and may influence virus infection. If so, in the native environment, the cross-reactive neutralizing antibodies, which recognize conformational epitopes in the middle of the stem region, may not generate escape mutants. Therefore, cross-protection induced by immunization with headless HA may be useful in the control of influenza.
Only inactivated vaccines have gained widespread use against influenza. However, one drawback is that their effectiveness is reduced by the frequent antigenic drift of influenza virus. Almost all the antigenic sites capable of eliciting neutralizing antibodies are located on the globular region and undergo antigenic change . Significant cross-protective antibody is not normally induced by virus infection or by immunization with current vaccines. It is possible, therefore, that the headless HA, which induces cross-protection, may be useful as a vaccine against emerging influenza viruses.
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